Specificity of Prohormone Convertase 2 on Proenkephalin and Proenkephalin-related Substrates*
暂无分享,去创建一个
D. Steiner | I. Lindberg | L. Juliano | M. Juliano | N. Lamango | C. Lazure | K. Johanning
[1] N. Seidah,et al. In Vitro Cleavage of Internally Quenched Fluorogenic Human Proparathyroid Hormone and Proparathyroid-related Peptide Substrates by Furin , 1998, The Journal of Biological Chemistry.
[2] I. Lindberg,et al. Prodynorphin Processing by Proprotein Convertase 2 , 1998, The Journal of Biological Chemistry.
[3] M L Agarwal,et al. The p53 Network* , 1998, The Journal of Biological Chemistry.
[4] B. Rist,et al. Role of prohormone convertases in pro-neuropeptide Y processing: coexpression and in vitro kinetic investigations. , 1997, Biochemistry.
[5] P. Halban,et al. Role of the prohormone convertase PC2 in the processing of proglucagon to glucagon , 1997, FEBS letters.
[6] L. Orci,et al. Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[7] J. Scharfstein,et al. Characterization of the substrate specificity of the major cysteine protease (cruzipain) from Trypanosoma cruzi using a portion-mixing combinatorial library and fluorogenic peptides. , 1997, The Biochemical journal.
[8] G. Krafft,et al. Internally consistent libraries of fluorogenic substrates demonstrate that Kex2 protease specificity is generated by multiple mechanisms. , 1997, Biochemistry.
[9] M. Beinfeld,et al. Cleavage of CCK 33 by recombinant PC2 in vitro. , 1997, Biochemical and biophysical research communications.
[10] I. Lindberg,et al. Processing Site Blockade Results in More Efficient Conversion of Proenkephalin to Active Opioid Peptides* , 1996, The Journal of Biological Chemistry.
[11] S. Brennan,et al. The specificity of the neuroendocrine convertase PC3 is determined by residues NH2‐ and COOH‐terminal to the cleavage site , 1996, Biochemistry and molecular biology international.
[12] I. Lindberg,et al. Purification and enzymatic characterization of recombinant prohormone convertase 2: stabilization of activity by 21 kDa 7B2. , 1996, Archives of biochemistry and biophysics.
[13] M. Schiller,et al. The processing proteases prohormone thiol protease, PC1/3 and PC2, and 70-kDa aspartic proteinase show preferences among proenkephalin, proneuropeptide Y, and proopiomelanocortin substrates. , 1996, Archives of biochemistry and biophysics.
[14] I. Lindberg,et al. Role of PC2 in Proenkephalin Processing: Antisense and Overexpression Studies , 1996, Journal of neurochemistry.
[15] N. Seidah,et al. Peptidyl substrates containing unnatural amino acid at the P'1 position are potent inhibitors of prohormone convertases. , 2009, International journal of peptide and protein research.
[16] Y. Loh,et al. Pro‐Thyrotropin‐Releasing Hormone Processing by Recombinant PC1 , 1995, Journal of neurochemistry.
[17] D. Steiner,et al. Proteolytic Processing Mechanisms in the Biosynthesis of Neuroendocrine Peptides: The Subtilisin-like Proprotein Convertases , 1995, Frontiers in Neuroendocrinology.
[18] N. Seidah,et al. Fluorescent Peptidyl Substrates as an Aid in Studying the Substrate Specificity of Human Prohormone Convertase PC1 and Human Furin and Designing a Potent Irreversible Inhibitor (*) , 1995, The Journal of Biological Chemistry.
[19] K. Docherty,et al. Differences between the catalytic properties of recombinant human PC2 and endogenous rat PC2. , 1995, The Biochemical journal.
[20] N. Seidah,et al. An internally quenched fluorogenic substrate of prohormone convertase 1 and furin leads to a potent prohormone convertase inhibitor. , 1995, The Biochemical journal.
[21] I. Lindberg,et al. Processing of Mouse Proglucagon by Recombinant Prohormone Convertase 1 and Immunopurified Prohormone Convertase 2 in Vitro(*) , 1995, The Journal of Biological Chemistry.
[22] G. Thomas,et al. Internally quenched fluorogenic substrate for furin. , 1995, Analytical biochemistry.
[23] Y. Loh,et al. In vitro processing of anthrax toxin protective antigen by recombinant PC1 (SPC3) and bovine intermediate lobe secretory vesicle membranes. , 1995, Archives of biochemistry and biophysics.
[24] Y. Loh,et al. In vitro processing of proopiomelanocortin by recombinant PC1 (SPC3). , 1994, Endocrinology.
[25] C. Gorman,et al. A survey of furin substrate specificity using substrate phage display , 1994, Protein science : a publication of the Protein Society.
[26] I. Lindberg,et al. Enzymatic properties of carboxyl-terminally truncated prohormone convertase 1 (PC1/SPC3) and evidence for autocatalytic conversion. , 1994, The Journal of biological chemistry.
[27] R. Mains,et al. Endoproteolytic processing of proopiomelanocortin and prohormone convertases 1 and 2 in neuroendocrine cells overexpressing prohormone convertases 1 or 2. , 1994, The Journal of biological chemistry.
[28] R. Siezen,et al. Homology modelling of the catalytic domain of human furin. A model for the eukaryotic subtilisin-like proprotein convertases. , 1994, European journal of biochemistry.
[29] K. Docherty,et al. Autocatalytic maturation of the prohormone convertase PC2. , 1994, The Journal of biological chemistry.
[30] H. Akil,et al. Processing of prodynorphin by the prohormone convertase PC1 results in high molecular weight intermediate forms , 1994, FEBS letters.
[31] A. Roebroek,et al. Furin-mediated proprotein processing activity: involvement of negatively charged amino acid residues in the substrate binding region. , 1994, Biochimie.
[32] N. Seidah,et al. Differential processing of proenkephalin by prohormone convertases 1(3) and 2 and furin. , 1993, The Journal of biological chemistry.
[33] J. Dixon,et al. Purification and characterization of the candidate prohormone-processing enzyme SPC3 produced in a mouse L cell line. , 1993, The Journal of biological chemistry.
[34] N. Seidah,et al. Enzymic characterization of murine and human prohormone convertase-1 (mPC1 and hPC1) expressed in mammalian GH4C1 cells. , 1993, The Biochemical journal.
[35] M. Rholam,et al. Role of beta-turn in proteolytic processing of peptide hormone precursors at dibasic sites. , 1993, Biochemistry.
[36] I. Lindberg,et al. Purification and characterization of the prohormone convertase PC1(PC3). , 1993, The Journal of biological chemistry.
[37] I. Lindberg,et al. Posttranslational processing of proenkephalin in AtT-20 cells: evidence for cleavage at a Lys-Lys site. , 1992, Endocrinology.
[38] S. Takahashi,et al. Purification and characterization of furin, a Kex2-like processing endoprotease, produced in Chinese hamster ovary cells. , 1992, The Journal of biological chemistry.
[39] R. Leduc,et al. Activation of human furin precursor processing endoprotease occurs by an intramolecular autoproteolytic cleavage. , 1992, The Journal of biological chemistry.
[40] I. Lindberg,et al. Posttranslational Processing of Proenkephalin in SK‐N‐MC Cells: Evidence for Phosphorylation , 1992, Journal of neurochemistry.
[41] C. Brenner,et al. Structural and enzymatic characterization of a purified prohormone-processing enzyme: secreted, soluble Kex2 protease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[42] D. Christie,et al. Identification of kex2-related proteases in chromaffin granules by partial amino acid sequence analysis. , 1991, The Journal of biological chemistry.
[43] I. Lindberg,et al. Posttranslational modifications of rat proenkephalin overexpressed in Chinese hamster ovary cells. , 1991, Endocrinology.
[44] M Chrétien,et al. cDNA sequence of two distinct pituitary proteins homologous to Kex2 and furin gene products: tissue-specific mRNAs encoding candidates for pro-hormone processing proteinases. , 1990, DNA and cell biology.
[45] R. Mains,et al. Cellular and molecular aspects of peptide hormone biosynthesis , 1990 .
[46] I. Lindberg,et al. Cleavage of proenkephalin by a chromaffin granule processing enzyme. , 1990, Endocrinology.
[47] I. Lindberg,et al. Distribution of immunoreactive peptide B in the rat brain. , 1986, Biochemical and biophysical research communications.
[48] D. Christie,et al. Characterization of the molecular forms of proenkephalin in bovine adrenal medulla and rat adrenal, brain, and spinal cord with a site-directed antiserum. , 1986, The Journal of biological chemistry.
[49] J. P. Schwartz,et al. A reduction of the tone of 5-hydroxytryptamine neurons decreases utilization rates of striatal and hypothalamic enkephalins. , 1984, European journal of pharmacology.
[50] I. Lindberg,et al. Distribution of met5-enkephalin-arg6-gly7-leu8-immunoreactive peptides in rat brain: Presence of multiple molecular forms , 1984, Brain Research.
[51] W. Hancock,et al. Antisera to synthetic peptide recognize high molecular weight enkephalin-containing proteins. , 1984, Biochemical and biophysical research communications.
[52] S. Udenfriend,et al. Biochemistry of the enkephalins and enkephalin-containing peptides. , 1983, Archives of biochemistry and biophysics.
[53] P. Giraud,et al. Enkephalins, ACTH, α-MSH and β-endorphin in human pheochromocytomas , 1981, Neuropeptides.